| Literature DB >> 28619820 |
Ivy Kim-Ni Chiang1, Martin Fritzsche2, Cathy Pichol-Thievend1, Alice Neal2, Kelly Holmes3, Anne Lagendijk1, Jeroen Overman1, Donatella D'Angelo4, Alice Omini4, Dorien Hermkens5, Emmanuelle Lesieur1, Ke Liu6, Indrika Ratnayaka2, Monica Corada7, George Bou-Gharios6, Jason Carroll3, Elisabetta Dejana7,8, Stefan Schulte-Merker5, Benjamin Hogan1, Monica Beltrame4, Sarah De Val9, Mathias Francois10.
Abstract
Arterial specification and differentiation are influenced by a number of regulatory pathways. While it is known that the Vegfa-Notch cascade plays a central role, the transcriptional hierarchy controlling arterial specification has not been fully delineated. To elucidate the direct transcriptional regulators of Notch receptor expression in arterial endothelial cells, we used histone signatures, DNaseI hypersensitivity and ChIP-seq data to identify enhancers for the human NOTCH1 and zebrafish notch1b genes. These enhancers were able to direct arterial endothelial cell-restricted expression in transgenic models. Genetic disruption of SoxF binding sites established a clear requirement for members of this group of transcription factors (SOX7, SOX17 and SOX18) to drive the activity of these enhancers in vivo Endogenous deletion of the notch1b enhancer led to a significant loss of arterial connections to the dorsal aorta in Notch pathway-deficient zebrafish. Loss of SoxF function revealed that these factors are necessary for NOTCH1 and notch1b enhancer activity and for correct endogenous transcription of these genes. These findings position SoxF transcription factors directly upstream of Notch receptor expression during the acquisition of arterial identity in vertebrates.Entities:
Keywords: Arterial enhancer; Artery; Endothelial cell; Human; Mouse; Notch1; SoxF; Transcriptional regulation; Zebrafish
Mesh:
Substances:
Year: 2017 PMID: 28619820 PMCID: PMC5536923 DOI: 10.1242/dev.146241
Source DB: PubMed Journal: Development ISSN: 0950-1991 Impact factor: 6.868